查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1930063

全球非處方藥市場：市場規模、市場佔有率、成長率、行業分析、依類型、應用和地區劃分的考察以及未來預測（2025-2034）

Over The Counter Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 請詢問到貨日

價格

非處方藥市場成長因素

2025年全球非處方藥市場規模將達到553.5億美元，預計2026年將成長至583.2億美元，最終在2034年達到943.2億美元，預測期內年複合成長率（CAGR）為6.10%。北美地區在2025年佔據市場主導地位，市場佔有率達到39.70%，這主要得益於消費者較高的用藥意識、完善的零售藥房基礎設施以及消費者對自我用藥的偏好。包括 Johnson & Johnson Services Inc.、Bayer AG、Novartis AG、Sanofi S.A.、Pfizer、GlaxoSmithKline Plc、Boehringer Ingelheim International GmbH、Reckitt Benckiser Group PLC在內的市場主要參與者，致力於產品上市、合作夥伴關係和數位化通路。

非處方藥是指無需處方即可購買的藥物，用於治療感冒、身體疼痛、過敏、流感、胃灼熱、痤瘡和輕微感染等常見疾病。它們透過醫院藥局、零售藥局以及越來越多的電商平台銷售。自我用藥的興起、處方藥向非處方藥的替代以及增強免疫力產品的上市，是推動市場成長的關鍵因素。例如，Hamdard 於2021年 1月推出了 12 種目的是增強免疫力的非處方藥。此外，非處方藥還能大幅節省成本，美國消費者每年透過使用非處方藥節省約 1,000億美元。

新冠疫情的影響

新冠疫情對非處方藥市場產生了不同的影響。由於人們對增強免疫力和緩解疼痛的意識增強，維生素、礦物質和止痛藥的需求增加；而咳嗽感冒藥、皮膚護理產品和消化系統藥物則因衛生措施和就診量減少而出現暫時性銷量下滑。儘管全球經濟動盪，強生服務公司和利潔時集團等公司仍報告其非處方藥業務收入成長。

市場趨勢

處方藥轉化為非處方藥的：一個關鍵趨勢是將處方藥轉化為非處方藥，提高藥物的可及性和可負擔性。例如，拜耳公司將一些處方藥轉化為非處方藥，用於自我保健。

自有品牌非處方藥及線上銷售：各公司紛紛推出自有品牌非處方藥，並與電商平台合作。Dr. Reddy's Laboratories Ltd.於2019年9月在美國推出了非處方奧美拉唑錠。由於網路普及率和成本優勢，線上銷售管道不斷擴大。

自有品牌非處方藥及線上銷售：各公司紛紛推出自有品牌非處方藥，並與電商平台合作。於2019年9月在美國推出了非處方奧美拉唑錠。由於網路普及率和成本優勢，線上銷售管道不斷擴大。

市場驅動因素

新產品上市：各大公司正致力於開發創新非處方藥。例如，Dr. Reddy's於2020年9月推出了用於緩解過敏症狀的鹽酸奧洛他定滴眼液。

可近性和價格優勢：非處方藥在零售店和線上平台的可近性推動了市場成長。處方藥轉為非處方藥的監管審批也進一步促進了其普及。例如，許多處方抗過敏藥物在2022年轉為非處方藥。

市場限制因子

自行用藥的風險：誤診、濫用、非處方藥的副作用都是限制因素。2020年，美國約有160萬12至25歲的年輕人濫用非處方藥，包括止咳藥和感冒藥。藥物濫用和傳統藥物的使用也影響市場成長。

市場區隔

依產品類型劃分：

  • 感冒咳嗽藥：由於季節性波動以及兒童和老年人的需求，預計到2026年，該細分市場將以 23.99%的市場佔有率佔據主導地位。
  • 止痛藥：由於人口老化和對止痛藥需求的不斷成長，預計該細分市場將成為第二大市場。
  • 維生素和礦物質：受預防醫學意識增強和能量補充劑需求成長的推動，預計該細分市場將成為第三大市場。
  • 其他細分市場包括胃腸道藥物、皮膚護理產品、助眠產品和體重管理產品。

依通路劃分：

  • 藥局和零售藥局：受消費者偏好和廣泛的零售網路驅動，預計到2026年將佔據 45.56%的市場佔有率。
  • 醫院藥局：由於便利性，市場佔有率位居第二。
  • 網路藥局：由於網路普及率和折扣優惠，成長迅速。

依地區劃分：

  • 北美：預計2025年將達到 219.6億美元，2026年將達到 232.4億美元。自我用藥趨勢和完善的基礎設施推動了市場發展。預計到2026年，美國非處方藥市場規模將達到 215.3億美元。
  • 歐洲：市場佔有率位居第二。預計到2026年，英國和德國的市場佔有率將分別達到 18.7億美元和 44.1億美元。 非處方藥的廣泛使用和公眾健康素養的提高為此提供了支持。
  • 亞太地區：預計該地區將經歷最快的成長。到2026年，日本預計將達到 29.5億美元，中國達到 42.5億美元，印度達到 21.9億美元。自我用藥、人口老化以及處方藥向非處方藥的轉變是推動成長的主要因素。
  • 拉丁美洲、中東和非洲：儘管市場規模較小，但由於醫療保健覆蓋範圍的擴大和非處方藥的廣泛使用，預計該地區將實現成長。

主要公司

主要公司包括Johnson & Johnson、Bayer AG、Novartis、Sanofi、Pfizer、GlaxoSmithKline、Boehringer Ingelheim、Reckitt Benckiser、Takeda Pharmaceutical、Perrigo。策略性措施包括產品上市、合作和資產剝離。主要進展包括：

  • 2023年6月：MCKESSON推出自有品牌非處方藥產品 "Foster & Thrive" 。
  • 2022年7月：RLG Limited與AFT Pharmaceuticals合作，透過天貓國際線上銷售非處方藥。
  • 2022年6月：Glenmark收購Wockhardt在美國的非處方藥ANDA申請。
  • 2022年3月：Perrigo的非處方藥 "Nasonex 24小時抗過敏藥" 獲得美國FDA核准。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會

第4章 主要考察

  • 新產品發布、主要參與者
  • 關鍵產業趨勢：併購、業務合作
  • 新冠疫情對市場的影響

第5章 全球非處方藥市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品類型
    • 止痛藥
    • 感冒咳嗽藥
    • 消化和腸道藥物
    • 皮膚保養產品
    • 維生素和礦物質
    • 其他
  • 市場分析、洞察與預測：依銷售管道劃分
    • 藥局和零售藥房
    • 醫院藥房
    • 線上藥房
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美非處方藥市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國（依產品類型）
    • 加拿大（依產品類型）

第7章 歐洲非處方藥市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 德國（依產品類型）
    • 英國（依產品類型）
    • 法國（依產品類型）
    • 西班牙（依產品類型）
    • 義大利（依產品類型）
    • 斯堪的納維亞半島（依產品類型）
    • 歐洲其他地區（依產品類型）

第8章 亞太地區非處方藥市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 日本（依產品類型）
    • 中國（依產品類型）
    • 印度（依產品類型）
    • 澳洲（依產品類型）
    • 東南亞（依產品類型）
    • 亞太其他地區（依產品類型）

第9章 拉丁美洲非處方藥市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 巴西（依產品類型）
    • 墨西哥（依產品類型）
    • 拉丁美洲其他地區（依產品類型）

第10章 中東與非洲非處方藥市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • GCC國家（依產品類型）
    • 南亞非洲（依產品類型）
    • 中東和非洲其他地區（依產品類型）

第11章 競爭分析

  • 全球市場佔有率分析（2024年）
  • 公司簡介
  • Johnson &Johnson Services Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Pfizer
  • GlaxoSmithKline Plc
  • Boehringer Ingelheim International GmbH
  • Reckitt Benckiser Group PLC
  • Takeda Pharmaceutical Company Ltd.
  • Perrigo Company plc
Product Code: FBI105433

Growth Factors of over-the-counter (OTC) drugs Market

The global over-the-counter (OTC) drugs market was valued at USD 55.35 billion in 2025 and is projected to grow to USD 58.32 billion in 2026, ultimately reaching USD 94.32 billion by 2034, reflecting a CAGR of 6.10% during the forecast period. North America dominated the market in 2025 with a 39.70% share, driven by high consumer awareness, strong retail pharmacy infrastructure, and a preference for self-medication. Key players in the market include Johnson & Johnson Services Inc., Bayer AG, Novartis AG, Sanofi S.A., Pfizer, GlaxoSmithKline Plc, Boehringer Ingelheim International GmbH, and Reckitt Benckiser Group PLC, focusing on product launches, partnerships, and digital distribution channels.

OTC drugs are pharmaceutical products available without a prescription and used to manage common health conditions such as colds, body pain, allergies, flu, heartburn, acne, and minor infections. They are sold through hospital pharmacies, retail drug stores, and increasingly via e-commerce platforms. The rising trend of self-medication, the switch of prescription drugs (Rx) to OTC, and the launch of immunity-boosting products are key drivers of market growth. For instance, Hamdard launched 12 OTC drugs for immunity in January 2021. Additionally, OTC products provide significant cost savings, with U.S. consumers saving approximately USD 100 billion annually by using non-prescription medicines.

COVID-19 Impact

The COVID-19 pandemic affected OTC markets differently. Vitamins & minerals and analgesics experienced heightened demand due to increased awareness of immunity and pain relief needs, while cough, cold, skin treatment, and digestive remedies saw a temporary decline in sales due to hygiene measures and reduced patient visits. Companies such as Johnson & Johnson Services Inc. and Reckitt Benckiser Group PLC reported revenue growth in their OTC segments despite global disruptions.

Market Trends

Rx-to-OTC Switch: A major trend is the conversion of prescription drugs to OTC products to increase accessibility and affordability. For example, Bayer AG has shifted some prescriptive drugs to OTC for self-care.

Private-Label OTC Products and Online Sales: Companies are increasingly launching private-label OTC products and partnering with e-commerce platforms. Dr. Reddy's Laboratories Ltd. launched an OTC Omeprazole tablet in the U.S. in September 2019. Online channels are expanding due to internet penetration and cost advantages.

Market Drivers

New Product Launches: Key players are focusing on developing innovative OTC products. For instance, Dr. Reddy's launched Olopatadine Hydrochloride Ophthalmic Solution in September 2020 for allergy relief.

Accessibility and Affordability: The availability of OTC products in retail stores and online platforms enhances market growth. Regulatory approvals for Rx-to-OTC switches further drive adoption. For example, many prescription allergy medicines transitioned to OTC in 2022.

Market Restraints

Self-Medication Risks: Misdiagnosis, misuse, and adverse effects from OTC drugs are restraining factors. In the U.S., around 1.6 million young people (ages 12-25) misused OTC medicines in 2020, including cough and cold products. Drug abuse and traditional medicine use also impact market growth.

Market Segmentation

By Product Type:

  • Cold & Cough Remedies: Dominated in 2026 with 23.99% share due to seasonal variations and prevalence in children and elderly populations.
  • Analgesics: Second-largest segment driven by aging populations and rising pain-relief demand.
  • Vitamins & Minerals: Third-largest, fueled by preventive health awareness and energy supplements.
  • Other segments include digestive & intestinal remedies, skin treatments, and sleeping aids/weight management products.

By Distribution Channel:

  • Drug Stores & Retail Pharmacies: Dominant with 45.56% share in 2026, due to consumer preference and extensive retail networks.
  • Hospital Pharmacies: Second-largest, driven by accessibility.
  • Online Pharmacies: Fast-growing due to internet penetration and discounts.

By Region:

  • North America: Valued at USD 21.96 billion in 2025, projected USD 23.24 billion in 2026; market leadership due to self-medication preference and strong infrastructure. U.S. OTC market expected at USD 21.53 billion in 2026.
  • Europe: Second-largest; UK USD 1.87 billion, Germany USD 4.41 billion in 2026, supported by OTC adoption and health literacy.
  • Asia Pacific: Fastest-growing; Japan USD 2.95 billion, China USD 4.25 billion, India USD 2.19 billion in 2026, driven by self-medication, aging population, and Rx-to-OTC shift.
  • Latin America & Middle East & Africa: Smaller shares, but growth fueled by increasing healthcare access and OTC adoption.

Key Industry Players

Major players include Johnson & Johnson, Bayer AG, Novartis, Sanofi, Pfizer, GlaxoSmithKline, Boehringer Ingelheim, Reckitt Benckiser, Takeda Pharmaceutical, and Perrigo. Strategic initiatives include product launches, partnerships, and divestitures. Notable developments include:

  • June 2023: MCKESSON launched private-brand OTC products, Foster & Thrive.
  • July 2022: RLG Limited partnered with AFT Pharmaceuticals to sell OTC drugs online via Tmall Global.
  • June 2022: Glenmark acquired OTC ANDAs from Wockhardt in the U.S.
  • March 2022: Perrigo received U.S. FDA approval for OTC Nasonex 24HR Allergy.

Conclusion

The global OTC drugs market is projected to grow from USD 55.35 billion in 2025 to USD 94.32 billion by 2034, driven by rising self-medication, Rx-to-OTC switches, product launches, and retail expansion. North America leads the market, while Asia Pacific demonstrates the fastest growth due to increasing health awareness and digital distribution channels. Cold & cough remedies dominate, followed by analgesics and vitamins & minerals. Strategic initiatives by key players, growing e-commerce adoption, and improved affordability will continue to propel market growth, ensuring wider access to safe and effective OTC medications globally.

Segmentation By Product Type

  • Analgesics
  • Cold & Cough Remedies
  • Digestives & Intestinal Remedies
  • Skin Treatment
  • Vitamins & Minerals
  • Others

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America (By Product Type, By Distribution Channel, and By Country)
    • The U.S. (By Product Type)
    • Canada (By Product Type)
  • Europe (By Product Type, By Distribution Channel, and By Country)
    • The U.K. (By Product Type)
    • Germany (By Product Type)
    • France (By Product Type)
    • Italy (By Product Type)
    • Spain (By Product Type)
    • Rest of Europe (By Product Type)
  • Asia Pacific (By Product Type, By Distribution Channel, and By Country)
    • China (By Product Type)
    • Japan (By Product Type)
    • India (By Product Type)
    • Australia (By Product Type)
    • Southeast Asia (By Product Type)
    • Rest of Asia Pacific (By Product Type)
  • Latin America (By Product Type, By Distribution Channel, and By Country)
    • Brazil (By Product Type)
    • Mexico (By Product Type)
    • Rest of Latin America (By Product Type)
  • Middle East & Africa (By Product Type, By Distribution Channel, and By Country)
    • GCC (By Product Type)
    • South Africa (By Product Type)
    • Rest of Middle East & Africa (By Product Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. New Product Launches, Key Players
  • 4.2. Recent Industry Developments - Partnerships, Mergers & Acquisitions
  • 4.3. Impact of Covid-19 on the Market

5. Global Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Analgesics
    • 5.1.2. Cold & Cough Remedies
    • 5.1.3. Digestives & Intestinal Remedies
    • 5.1.4. Skin Treatment
    • 5.1.5. Vitamins & Minerals
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 5.2.1. Drug Stores & Retail Pharmacies
    • 5.2.2. Hospital Pharmacies
    • 5.2.3. Online Pharmacies
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Analgesics
    • 6.1.2. Cold & Cough Remedies
    • 6.1.3. Digestives & Intestinal Remedies
    • 6.1.4. Skin Treatment
    • 6.1.5. Vitamins & Minerals
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 6.2.1. Drug Stores & Retail Pharmacies
    • 6.2.2. Hospital Pharmacies
    • 6.2.3. Online Pharmacies
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S. (By Product Type)
    • 6.3.2. Canada (By Product Type)

7. Europe Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Analgesics
    • 7.1.2. Cold & Cough Remedies
    • 7.1.3. Digestives & Intestinal Remedies
    • 7.1.4. Skin Treatment
    • 7.1.5. Vitamins & Minerals
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 7.2.1. Drug Stores & Retail Pharmacies
    • 7.2.2. Hospital Pharmacies
    • 7.2.3. Online Pharmacies
  • 7.3. Market Analysis, Insights and Forecast - By Country
    • 7.3.1. Germany (By Product Type)
    • 7.3.2. U.K. (By Product Type)
    • 7.3.3. France (By Product Type)
    • 7.3.4. Spain (By Product Type)
    • 7.3.5. Italy (By Product Type)
    • 7.3.6. Scandinavia (By Product Type)
    • 7.3.7. Rest of Europe (By Product Type)

8. Asia Pacific Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Analgesics
    • 8.1.2. Cold & Cough Remedies
    • 8.1.3. Digestives & Intestinal Remedies
    • 8.1.4. Skin Treatment
    • 8.1.5. Vitamins & Minerals
    • 8.1.6. Others
  • 8.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 8.2.1. Drug Stores & Retail Pharmacies
    • 8.2.2. Hospital Pharmacies
    • 8.2.3. Online Pharmacies
  • 8.3. Market Analysis, Insights and Forecast - By Country
    • 8.3.1. Japan (By Product Type)
    • 8.3.2. China (By Product Type)
    • 8.3.3. India (By Product Type)
    • 8.3.4. Australia (By Product Type)
    • 8.3.5. Southeast Asia (By Product Type)
    • 8.3.6. Rest of Asia Pacific (By Product Type)

9. Latin America Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Analgesics
    • 9.1.2. Cold & Cough Remedies
    • 9.1.3. Digestives & Intestinal Remedies
    • 9.1.4. Skin Treatment
    • 9.1.5. Vitamins & Minerals
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 9.2.1. Drug Stores & Retail Pharmacies
    • 9.2.2. Hospital Pharmacies
    • 9.2.3. Online Pharmacies
  • 9.3. Market Analysis, Insights and Forecast - By Country
    • 9.3.1. Brazil (By Product Type)
    • 9.3.2. Mexico (By Product Type)
    • 9.3.3. Rest of Latin America (By Product Type)

10. Middle East & Africa Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Analgesics
    • 10.1.2. Cold & Cough Remedies
    • 10.1.3. Digestives & Intestinal Remedies
    • 10.1.4. Skin Treatment
    • 10.1.5. Vitamins & Minerals
    • 10.1.6. Others
  • 10.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 10.2.1. Drug Stores & Retail Pharmacies
    • 10.2.2. Hospital Pharmacies
    • 10.2.3. Online Pharmacies
  • 10.3. Market Analysis, Insights and Forecast - By Country
    • 10.3.1. GCC Countries (By Product Type)
    • 10.3.2. South Africa (By Product Type)
    • 10.3.3. Rest of Middle East & Africa (By Product Type)

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
    • 11.2.1. Johnson & Johnson Services Inc.
      • 11.2.1.1. Overview,
      • 11.2.1.2. Products,
      • 11.2.1.3. SWOT,
      • 11.2.1.4. Recent Developments,
      • 11.2.1.5. Strategies,
      • 11.2.1.6. Financials (based on availability)
    • 11.2.2. Bayer AG
      • 11.2.2.1. Overview,
      • 11.2.2.2. Products,
      • 11.2.2.3. SWOT,
      • 11.2.2.4. Recent Developments,
      • 11.2.2.5. Strategies,
      • 11.2.2.6. Financials (based on availability)
    • 11.2.3. Novartis AG
      • 11.2.3.1. Overview,
      • 11.2.3.2. Products,
      • 11.2.3.3. SWOT,
      • 11.2.3.4. Recent Developments,
      • 11.2.3.5. Strategies,
      • 11.2.3.6. Financials (based on availability)
    • 11.2.4. Sanofi S.A.
      • 11.2.4.1. Overview,
      • 11.2.4.2. Products,
      • 11.2.4.3. SWOT,
      • 11.2.4.4. Recent Developments,
      • 11.2.4.5. Strategies,
      • 11.2.4.6. Financials (based on availability)
    • 11.2.5. Pfizer
      • 11.2.5.1. Overview,
      • 11.2.5.2. Products,
      • 11.2.5.3. SWOT,
      • 11.2.5.4. Recent Developments,
      • 11.2.5.5. Strategies,
      • 11.2.5.6. Financials (based on availability)
    • 11.2.6. GlaxoSmithKline Plc
      • 11.2.6.1. Overview,
      • 11.2.6.2. Products,
      • 11.2.6.3. SWOT,
      • 11.2.6.4. Recent Developments,
      • 11.2.6.5. Strategies,
      • 11.2.6.6. Financials (based on availability)
    • 11.2.7. Boehringer Ingelheim International GmbH
      • 11.2.7.1. Overview,
      • 11.2.7.2. Products,
      • 11.2.7.3. SWOT,
      • 11.2.7.4. Recent Developments,
      • 11.2.7.5. Strategies,
      • 11.2.7.6. Financials (based on availability)
    • 11.2.8. Reckitt Benckiser Group PLC
      • 11.2.8.1. Overview,
      • 11.2.8.2. Products,
      • 11.2.8.3. SWOT,
      • 11.2.8.4. Recent Developments,
      • 11.2.8.5. Strategies,
      • 11.2.8.6. Financials (based on availability)
    • 11.2.9. Takeda Pharmaceutical Company Ltd.
      • 11.2.9.1. Overview,
      • 11.2.9.2. Products,
      • 11.2.9.3. SWOT,
      • 11.2.9.4. Recent Developments,
      • 11.2.9.5. Strategies,
      • 11.2.9.6. Financials (based on availability)
    • 11.2.10. Perrigo Company plc
      • 11.2.10.1. Overview,
      • 11.2.10.2. Products,
      • 11.2.10.3. SWOT,
      • 11.2.10.4. Recent Developments,
      • 11.2.10.5. Strategies,
      • 11.2.10.6. Financials (based on availability)

List of Tables

  • Table 1: Global Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 3: Global Over The Counter Drugs Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 5: North America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 6: North America Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: U.S. Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 8: Europe Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 9: Europe Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: Europe Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 11: U.K. Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 12: Germany Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 13: France Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 14: Italy Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 15: Spain Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 16: Rest of Europe Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 17: Asia Pacific Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 18: Asia Pacific Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 19: Asia Pacific Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 20: China Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 21: India Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 22: Japan Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 23: Australia Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 24: Southeast Asia Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 25: Rest of Asia Pacific Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 27: Latin America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 28: Latin America Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Brazil Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 30: Mexico Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 31: Rest of Latin America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 33: Middle East & Africa Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 34: Middle East & Africa Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 35: GCC Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 36: South Africa Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 37: Rest of Middle East Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

List of Figures

  • Figure 1: Global Over The Counter Drugs Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Over The Counter Drugs Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 4: Global Over The Counter Drugs Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 6: North America Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 7: North America Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 8: North America Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 9: North America Over The Counter Drugs Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Over The Counter Drugs Market Value Share (%), By Country, 2025
  • Figure 11: Europe Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 12: Europe Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 13: Europe Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: Europe Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: Europe Over The Counter Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Over The Counter Drugs Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 18: Asia Pacific Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 19: Asia Pacific Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 20: Asia Pacific Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 21: Asia Pacific Over The Counter Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Over The Counter Drugs Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 24: Latin America Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 25: Latin America Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 26: Latin America Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 27: Latin America Over The Counter Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Over The Counter Drugs Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 30: Middle East & Africa Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 31: Middle East & Africa Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 32: Middle East & Africa Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 33: Middle East & Africa Over The Counter Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Over The Counter Drugs Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Over The Counter Drugs Market Share (%), By Company, 2025